Abstract
Vibrio harveyi is a kind of pathogenic bacteria that occurs widely in the ocean and exhibits multiple drug resistance. V. harveyi hemolysin (VHH) is the essential virulence factor of V. harveyi, and its main function is to promote the entry and spread of V. harveyi by lysing the cell membrane, which plays a critical role in the pathogen infection of the host. In this study, we used VHH as the target protein of novel virulence factor inhibitors and found that resveratrol (RSV) significantly inhibited its hemolytic activity. Furthermore, we investigated the mechanism of action of RSV and evaluated its therapeutic effect in V. harveyi-infected Takifugu rubripes. Remarkably, RSV downregulated the transcription of the vhh gene within a concentration range that did not inhibit bacterial growth. In addition, RSV antagonized its hemolytic activity by directly binding to the active center of VHH. RSV could effectively inhibit the damage caused by VHH and V. harveyi both in vitro and in vivo. These results suggest that RSV is a promising agent for the treatment of V. harveyi infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
